In The News,
Value Based Payment for Gene Therapy
ADVI helped develop an outcomes-based payment approach for a one-time, curative gene therapy manufacturer to use in reimbursement discussions with state Medicaid programs and commercial payers. ADVI’s gene therapy experience spans 16 different manufacturers and 20 different therapeutic areas.
Interested in hearing more from us?
Receive customized email alerts from the ADVI team